Tau PET correlates closely with cognitive decline in Alzheimer’s disease, making it a potential surrogate outcome measure. Yet in amyloid immunotherapy trials to date, this signal has not always ...

A team from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) has demonstrated that tau PET -- a novel imaging technique for visualising the tau protein -- can predict ...

A new tau PET radiotracer, 18F-SNFT-1, has been found to be more effective than existing tau PET radiotracers in identifying Alzheimer’s disease in its earliest stages, according to research.

A new tau PET radiotracer, 18 F-SNFT-1, has been found to be more effective than existing tau PET radiotracers in identifying Alzheimer's disease in its earliest stages, according to research ...

Plasma eMTBR-tau243 shows a strong correlation with tau pathology and cognitive decline, offering a less invasive alternative to tau-PET imaging. Study: Plasma MTBR-tau243 biomarker identifies tau ...

Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for ...

The new Centiloid scoring feature is a method to standardise beta-amyloid plaque quantification in PET scans across various radiopharmaceuticals. The second feature focuses on tau PET ...

Researchers prospectively collected blood samples from 10 individuals who were tau-PET positive, as well as from 22 age-matched healthy individuals, at four global sites. They then used Sunbird ...

Tau imaging with 18F-Flortaucipir PET in Alzheimer’s disease. The figure shows a prototypical tau accumulation pattern, obtained by comparing tau load of patients with Alzheimer’s disease vs ...

Tau imaging with 18F-Flortaucipir PET in Alzheimer’s disease. The figure shows a prototypical tau accumulation pattern, obtained by comparing tau load of patients with Alzheimer’s disease vs ...